col0,col1,col2,col3,col4,col5,col6,col7,col8,col9,col10,col11,col12,col13,col14,col15,col16,col17,col18,col19,col20,col21,col22,col23,col24,col25,col26,col27,col28,col29,col30,col31,col32,col33,col34,col35,col36,col37,col38,col39,col40,col41
subject,,,,cell_subset,,,cell_subset,,,,,,,,,,,,,pathogen,,,,,,,,,,,,,,,,,,,,vaccine,vaccine
evidence,,,,,label,label,,label,label,label,label,label,label,label,label,label,label,label,label,,label,label,label,label,label,label,label,label,label,label,url,label,label,label,label,label,label,label,file,,
role,,,,tissue,observed,observed,cell_biomarker,observed,observed,observed,observed,observed,background,measured,background,background,observed,observed,background,pathogen,background,background,observed,background,background,background,background,background,background,background,reference,observed,observed,observed,observed,background,background,background,observed,vaccine,vaccine
mime_type,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
numeric_units,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
display_text,,,,tissue type,response component (original cell type),response component (original) count,response component (cell subset),response component count,cell ontology ID,cell type PRO and extra terms,protein ontology ID,all response components in signature,response behavior type,response behavior,comparison,subgroup,time point,time point units,baseline time,target pathogen,vaccine year,exposure material - additional,cohort,adjuvant,route,publication reference (PMID),publication year,"signature source figure, table or text section",signature source url,comments and additional details,Loxton et al. (2017) Safety and Immunogenicity of the Recombinant Mycobacterium bovis BCG Vaccine VPM1002 in HIV-Unexposed Newborn Infants in South Africa. Clin Vaccine Immunol. PMID: <a href = 'https://www.ncbi.nlm.nih.gov/pubmed/?term=27974398' target='_blank'>27974398</a>,cohort,age min.,age max.,age units,ID of observation within its own submission,Uniq ID of observation within its submission type,row key,response component (cell types) file,exposure material 1 (VO),exposure material 2 (VO)
,hipc_ctf_27974398_2,2017.02,hipc_ctf_27974398_2,blood,CD8+ interleukin-17+ (IL-17+) cells,1,"CD8-positive, alpha-beta T cell",1,CL_0000625,& IL17A+,PR:000001138,"CD8-positive, alpha-beta T cell & IL17A+",cell type frequency,up,6m vs 0m,none,6,Months,time of vaccination (first dose),mycobacterium tuberculosis variant bovis BCG,,,infants,,,27974398,2017,Fig 4B,<a href = 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5299117/figure/F4/' target='_blank'>figure/F4</a>,,https://www.ncbi.nlm.nih.gov/pubmed/?term=27974398,infants,,,,2,44,27974398_2_44,hipc_ctf_sig_27974398_2.txt,VO_0000771,VO_0003131
